Muscular Dystrophy-Dystroglycanopathy , Type a, 4 (MDDGA4)

Alias:

Fukuyama Congenital Muscular Dystrophy

Fcmd

Congenital Muscular Dystrophy, Fukuyama Type

Fukuyama Type Congenital Muscular Dystrophy

Fktn-Related Congenital Muscular Dystrophy

Mddga4

Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies A4

Muscular Dystrophy, Congenital, with Central Nervous System Involvement

Muscular Dystrophy, Congenital Progressive, with Mental Retardation

Walker-Warburg Syndrome or Muscle-Eye-Brain Disease, Fktn-Related

Dystrophy, Muscular, Dystroglycanopathy , Type A4

Muscular Dystrophy, Congenital, Fukuyama Type

Congenital Muscular Dystrophy Fukuyama Type

Cerebromuscular Dystrophy, Fukuyama Type

Cerebromuscular Dystrophy Fukuyama Type

Polymicrogyria with Muscular Dystrophy

Micropolygyria with Muscular Dystrophy

Muscle-Eye-Brain Disease Fktn-Related

Walker-Warburg Syndrome Fktn-Related

Fukuyama-Type Muscular Dystrophy

Fukuyama Muscular Dystrophy

Fukuyama Syndrome

Fukuyama Cmd

Favorite

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Muscular Dystrophy-Dystroglycanopathy , Type a, 4, also known as fukuyama congenital muscular dystrophy, is related to cardiomyopathy, dilated, 1x and lissencephaly 2, and has symptoms including seizures An important gene associated with Muscular Dystrophy-Dystroglycanopathy , Type a, 4 is FKTN (Fukutin), and among its related pathways/superpathways are Metabolism of proteins and Extracellular matrix organization. Affiliated tissues include eye and brain, and related phenotypes are gait disturbance and hypotonia

Related ID：

MALACARDS：MSC037

OMIM：253800

MESH：D058494